ACADIA Pharmaceuticals
ACAD
#4041
Rank
NZ$5.59 B
Marketcap
NZ$32.39
Share price
-2.67%
Change (1 day)
-22.99%
Change (1 year)

Market capitalization of ACADIA Pharmaceuticals (ACAD)

Market cap: NZ$5.59 Billion

As of November 2026 ACADIA Pharmaceuticals has a market cap of NZ$5.59 Billion. This makes ACADIA Pharmaceuticals the world's 4041th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ACADIA Pharmaceuticals from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$5.59 B-28.74%
2025NZ$7.85 B44.81%
2024NZ$5.42 B-33.27%
2023NZ$8.12 B100.19%
2022NZ$4.06 B-26.08%
2021NZ$5.49 B-53.36%
2020NZ$11.77 B19.42%
2019NZ$9.86 B184.42%
2018NZ$3.46 B-34.15%
2017NZ$5.26 B4.43%
2016NZ$5.04 B-5.03%
2015NZ$5.30 B30.97%
2014NZ$4.05 B46.34%
2013NZ$2.77 B568.35%
2012NZ$0.41 B467.33%
2011NZ$73.06 M19.37%
2010NZ$61.2 M-12.14%
2009NZ$69.66 M20.82%
2008NZ$57.65 M-89.23%
2007NZ$0.53 B43.28%
2006NZ$0.37 B53.88%
2005NZ$0.24 B51.89%
2004NZ$0.15 B

End of Day market cap according to different sources

On Nov 18th, 2026 the market cap of ACADIA Pharmaceuticals was reported to be:

NZ$5.59 Billion
by Nasdaq info icon info icon
NZ$5.59 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.192 T 21,203.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$290.51 B 5,090.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$2.237 T 39,869.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$221.13 B 3,850.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
NZ$0.41 B-92.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
NZ$0.68 B-87.79%๐Ÿ‡บ๐Ÿ‡ธ USA